Cargando…
Synergistic Effects of New Curcumin Analog (PAC) and Cisplatin on Oral Cancer Therapy
Oral cancer has traditionally been treated with surgery, radiotherapy, chemotherapy, or a combination of these therapies. Although cisplatin, a chemotherapy drug, can effectively kill oral cancer cells by forming DNA adducts, its clinical use is limited due to adverse effects and chemo-resistance. T...
Autores principales: | Semlali, Abdelhabib, Beji, Sarra, Ajala, Ikram, Al-Zharani, Mohammed, Rouabhia, Mahmoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297365/ https://www.ncbi.nlm.nih.gov/pubmed/37367068 http://dx.doi.org/10.3390/cimb45060319 |
Ejemplares similares
-
Synergistic Effect of Anethole and Platinum Drug Cisplatin against Oral Cancer Cell Growth and Migration by Inhibiting MAPKase, Beta-Catenin, and NF-κB Pathways
por: Semlali, Abdelhabib, et al.
Publicado: (2023) -
The Curcumin Analog PAC Is a Potential Solution for the Treatment of Triple-Negative Breast Cancer by Modulating the Gene Expression of DNA Repair Pathways
por: Almalki, Esraa, et al.
Publicado: (2023) -
The curcumin analog (PAC) suppressed cell survival and induced apoptosis and autophagy in oral cancer cells
por: Semlali, Abdelhabib, et al.
Publicado: (2021) -
Rapamycin inhibits oral cancer cell growth by promoting oxidative stress and suppressing ERK1/2, NF-κB and beta-catenin pathways
por: Semlali, Abdelhabib, et al.
Publicado: (2022) -
Oxidative Stress and Autophagy Mediate Anti-Cancer Properties of Cannabis Derivatives in Human Oral Cancer Cells
por: Loubaki, Lionel, et al.
Publicado: (2022)